Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study

Pushpa Narayanaswami(Northwestern University), Gilles Hoffmann, Rishi Desai(Harvard University), Jason R. Blevins(Clinical Research Institute), Michael Nicolle, Neelam Goyal, Volkan Granit(Biohaven Pharmaceuticals (United States)), Kristina A. Brown, Waqar Waheed(Erasmus MC), Michael Benatar(University of Miami), Hilda Gutiérrez, Haley Andonian, Michael K. Hehir, James F. Howard(University of North Carolina at Chapel Hill), Denise Hulley, Araya Puwanant(Beth Israel Deaconess Medical Center), David Polston, Emma Ciafaloni(University of Rochester Medical Center), Laine Thomas(Clinical Research Institute), Katherine Ruzhansky, David Lacomis, Jeffrey T. Guptill(Duke University), David H. Weinberg(The Ohio State University), Kathie Bibeau(Myasthenia Gravis Foundation of America), Rabia Malik, Aparna Choudhury, Shawn Bird, Zaeem A. Siddiqi, Vern C. Juel, Patricia P. Smith, Noah Kolb(Erasmus MC), Steven J. Shook, Shruti M. Raja, Avery B. St. Sauveur, C. Douglas Emmet, Anne-Laure Gringon, Yuebing Li(Duke University), Donald B. Sanders(Duke Medical Center), Muhammed Abid Alvi, Janice M. Massey, Manisha Chopra, Daniel G. Larriviere, Debbie Hastings, Kristin Johnson, Andrew Krueger, Dylan Thibault(Clinical Research Institute), Lisa D. Hobson‐Webb(Duke Medical Center), Karissa Gable, Bo Liu(Hebei North University), Srikanth Muppidi(Stanford University)
The Lancet Neurology
February 14, 2024
Cited by 53


Related Papers